{"id":9111,"date":"2025-10-03T00:08:17","date_gmt":"2025-10-03T00:08:17","guid":{"rendered":"https:\/\/polikistikover.net\/yeni\/?page_id=9111"},"modified":"2025-11-25T22:47:05","modified_gmt":"2025-11-25T22:47:05","slug":"polikistik-over-sendromunda-et-benleri-3","status":"publish","type":"page","link":"https:\/\/polikistikover.net\/yeni\/polikistik-over-sendromunda-et-benleri-3\/","title":{"rendered":"Polikistik Over Sendromu\u2019nda Et Benleri"},"content":{"rendered":"
\n
\"\"<\/figure>\n<\/div>\n\n\n

Boyun b\u00f6lgesinde et benleri (Skin Tags)<\/em><\/strong><\/p>\n\n\n\n

Polikistik over sendromu\u2019nda fazla kilolu ve \u015fi\u015fman olan veya normal kilolu fakat bel \u00e7evresi kal\u0131n (<\/em>erkek tipi ya\u011flanma)<\/em> olan kad\u0131nlar\u0131n b\u00fcy\u00fck \u00e7o\u011funlu\u011funda ins\u00fclin direnci <\/a>g\u00f6r\u00fclmektedir(1,2,3,4).<\/mark><\/strong><\/p>\n\n\n\n

Polikistik over sendromu olan normal kilolu veya zay\u0131f ya da fazla kilolu veya \u015fi\u015fman kad\u0131nlar\u0131n bir k\u0131sm\u0131nda kar\u0131n ve bel \u00e7evresinde ya\u011f miktar\u0131 fazla <\/a>(<\/em>erkek tipi ya\u011flanma)<\/em> oldu\u011fu i\u00e7in ins\u00fclin direncinin bir g\u00f6stergesi olan bel \u00e7evresi kal\u0131nl\u0131\u011f\u0131 g\u00f6r\u00fclmektedir(5,6,7,8).<\/p>\n\n\n\n

 Polikistik over sendromu ve ins\u00fclin direnci olan <\/a>fazla kilolu <\/a>kad\u0131nlarda deriye sapla ba\u011fl\u0131 et benleri (Skin Tags) (acrochordon) g\u00f6r\u00fclebilir(13).<\/mark><\/strong><\/p>\n\n\n\n

Bu et benleri \u015feker hastal\u0131\u011f\u0131n\u0131n \u00f6nc\u00fc bir belirtisi olup \u00f6zellikle s\u00fcrt\u00fcnmenin fazla oldu\u011fu boyun, koltuk alt\u0131, g\u00f6\u011f\u00fcs ve kas\u0131k gibi b\u00f6lgelerde ortaya \u00e7\u0131kar.<\/p>\n\n\n\n

Tedavi; <\/strong><\/p>\n\n\n\n

Tedavinin amac\u0131 ins\u00fclin direncine kar\u015f\u0131 \u201d\u0130ns\u00fclin duyarl\u0131l\u0131\u011f\u0131\u201dn\u0131n artt\u0131r\u0131lmas\u0131d\u0131r(9,10,11,12).<\/mark><\/strong><\/p>\n\n\n\n

\u0130ns\u00fclin direncinin azalt\u0131lmas\u0131 ve ins\u00fclin direncine ba\u011fl\u0131 olarak fazla miktarda \u00fcretilen ins\u00fclin hormonunun normal seviyelere d\u00fc\u015f\u00fcr\u00fclmesidir.<\/p>\n\n\n\n

Kaynaklar<\/strong><\/p>\n\n\n\n

1-Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Diabetes. 1989 Sep;38(9):1165-74.<\/p>\n\n\n\n

2-Prediction models for insulin resistance in the polycystic ovary syndrome. Gennarelli G, Holte J, Berglund L, Berne C, Massobrio M, Lithell H. Hum Reprod. 2000 Oct;15(10):2098-102.<\/p>\n\n\n\n

3-Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. carmina E , Lobo RA. Fertil Steril. 2004  Sep;82(3):661-5.<\/p>\n\n\n\n

4-Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. DeUgarte CM, Bartolucci AA, Azziz R. Fertil Steril. 2005 May;83(5):1454-60.<\/p>\n\n\n\n

5-Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. Moran LJ, Misso ML, Wild RA, Norman RJ. 2010 Jul-Aug;16(4):347-63.<\/p>\n\n\n\n

6-Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo RA. Fertil Steril. 2009 Apr;91(4 Suppl):1332-5.<\/p>\n\n\n\n

7-Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Kirchengast S, Huber J. Hum Reprod. 2001 Jun;16(6):1255-60.<\/p>\n\n\n\n

8-Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Orio F, Di Fede G, Rini G. J Clin Endocrinol Metab. 2007 Jul;92(7):2500-5.<\/p>\n\n\n\n

9-Insulin resistance and polycystic ovary syndrome through life. Diamanti-Kandarakis E, Spritzer PM, Sir-Petermann T, Motta AB. Curr Pharm Des. 2012;18(34):5569-76.<\/p>\n\n\n\n

10-Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Fertil Steril. 2009 Dec;92(6):1966-82.<\/p>\n\n\n\n

11-Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E, Muggeo M. J Clin Endocrinol Metab. 2000 Jan;85(1):139-46.<\/p>\n\n\n\n

12-Insulin-lowering agents in the management of polycystic ovary syndrome. De Leo V, la Marca A, Petraglia F. Endocr Rev. 2003 Oct;24(5):633-67.
13-Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity. G. S. Conway and H. S. Jacobs. Postgrad Med J. 1990 Jul; 66(777): 536\u2013538.<\/p>\n","protected":false},"excerpt":{"rendered":"

Boyun b\u00f6lgesinde et benleri (Skin Tags) Polikistik over sendromu\u2019nda fazla kilolu ve \u015fi\u015fman olan veya normal kilolu fakat bel \u00e7evresi kal\u0131n (erkek tipi ya\u011flanma) olan kad\u0131nlar\u0131n b\u00fcy\u00fck \u00e7o\u011funlu\u011funda ins\u00fclin direnci g\u00f6r\u00fclmektedir(1,2,3,4). Polikistik over sendromu olan normal kilolu veya zay\u0131f ya da fazla kilolu veya \u015fi\u015fman kad\u0131nlar\u0131n bir k\u0131sm\u0131nda kar\u0131n ve bel \u00e7evresinde ya\u011f miktar\u0131 fazla (erkek tipi ya\u011flanma) oldu\u011fu i\u00e7in […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-9111","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/polikistikover.net\/yeni\/wp-json\/wp\/v2\/pages\/9111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/polikistikover.net\/yeni\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/polikistikover.net\/yeni\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/polikistikover.net\/yeni\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/polikistikover.net\/yeni\/wp-json\/wp\/v2\/comments?post=9111"}],"version-history":[{"count":12,"href":"https:\/\/polikistikover.net\/yeni\/wp-json\/wp\/v2\/pages\/9111\/revisions"}],"predecessor-version":[{"id":11747,"href":"https:\/\/polikistikover.net\/yeni\/wp-json\/wp\/v2\/pages\/9111\/revisions\/11747"}],"wp:attachment":[{"href":"https:\/\/polikistikover.net\/yeni\/wp-json\/wp\/v2\/media?parent=9111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}